The scaffold hopping potential of pharmacophores

Drug Discovery Today: Technologies

Volumn 7, Issue 4, 2010, Pages

  Hessler, Gerhard ^a   Baringhaus, Karl Heinz ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR SCAFFOLD;

ARTICLE; CHEMICAL ANALYSIS; DATA BASE; DRUG ACTIVITY; PHARMACOPHORE; PROTEIN INTERACTION; SCORING SYSTEM; SCREENING TEST; STRUCTURE ANALYSIS;

EID: 78650740515     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2010.09.001     Document Type: Review

References (42)

1. A.R. Leach Three-dimensional pharmacophore methods in drug discovery J. Med. Chem. 53 2010 539 558
2. G. Wolber Molecule-pharmacophore superpositioning and pattern matching in computational drug design Drug Discov. Today 13 2008 23 29
3. Y.C. Martin Pharmacophore Modelling: 1 - Methods J.B. Taylor, D.J. Triggle, Methods in Comprehensive Medicinal Chemistry II 2007 Elsevier Ltd 119 147
4. H. Mauser, and W. Guba Recent developments in de novo design and scaffold hopping Curr. Opin. Drug Discov. Dev. 11 2008 365 374
5. H-J. Böhm Scaffold hopping Drug Discov. Today: Technol. 1 2004 217 224
6. G. Schneider Scaffold-hopping: How far can you jump? QSAR Comb. Sci. 25 2006 1162 1171
7. S.R. Langdon Bioisosteric replacement and scaffold hopping in lead generation and optimization Mol. Inf. 29 2010 366 385
8. G. Lauri, and P. Bartlett CAVEAT: a program to facilitate the design of organic molecules J. Comput. Aid. Mol. Des. 8 1994 51 66
9. P. Maass Recore: a fast and versatile method for scaffold hopping based on small molecule crystal structure conformations J. Chem. Inf. Model. 47 2007 390 398
10. A.J. Jakobi ParaFrag - an approach for surface-based similarity comparison of molecular fragments J. Mol. Model. 14 2008 547 558
11. R. Bergmann SHOP: Scaffold HOPping by GRID-based similarity searches J. Med. Chem. 50 2007 2708 2717
12. P.J. Goodford A computational procedure for determining energetically favorable binding sites on biologically important macromolecules J. Med. Chem. 28 1985 849 857
13. X. Lewell RECAP-retrosynthetic combinatorial and analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful application in combinatorial chemistry J. Chem. Inf. Comput. Sci. 38 1998 511 522
14. N. Brown, and E. Jacoby On scaffolds and hopping in medicinal chemistry Mini-Rev. Med. Chem. 6 2006 1217 1229
15. U. Fechner Comparison of correlation vector methods for ligand-based similarity searching J. Comput. Aid. Mol. Des. 17 2003 687 698
16. S. Renner Alignment-free pharmacophore patterns - a correlation-vector approach T. Langer, R.D. Hoffmann, Pharmacophores and Pharmacophore Searches 2006 Wiley-VCH 49 77
17. L. Franke Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening J. Med. Chem. 50 2007 2640 2646
18. M. Rarey, and J.S. Dixon Feature trees: a new molecular similarity measure based on tree matching J. Comput. Aid. Mol. Des. 12 1998 471 490
19. A.C. Good Measuring CAMD technique performance: a virtual screening case study in the design of validation experiments J. Comput. Aid. Mol. Des. 18 2004 529 536
20. M. Baroni A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): theory and application J. Chem. Inf. Model. 47 2007 279 294
21. E. Carosati Virtual screening for novel openers of pancreatic KATP channels J. Med. Chem. 50 2007 2117 2126
22. M. Whittle Analysis of data fusion methods in virtual screening: similarity and group fusion J. Chem. Inf. Model. 46 2006 2206 2219 (Pubitemid 46008096)
23. S.W. Muchmore Application of belief theory to similarity data fusion for use in analog searching and lead hopping J. Chem. Inf. Model. 48 2008 941 948
24. Y.C. Martin, and S.W. Muchmore Beyond QSAR: lead hopping to different structures QSAR Comb. Sci. 28 2009 797 801
25. G. Hessler Multiple-ligand-based virtual screening: methods and applications of the MTree approach J. Med. Chem. 48 2005 6575 6584
26. M. Rupp From machine learning to natural product derivatives that selectively activate transcription factor PPARγ ChemMedChem 5 2010 191 194
27. A. Ghose, and G. Crippen Atomic physicochemical parameters for three-dimensional structure-directed quantitative structure-activity relationships. I. Partition coefficients as a measure of hydrophobicity J. Comp. Chem. 7 1986 565 577
28. A. Ghose Atomic physicochemical parameters for three-dimensional- structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions J. Chem. Inf. Comp. Sci. 27 1987 21 35
29. A. Ghose Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships III: modeling hydrophobic interactions J. Comp. Chem. 9 1988 80 90
30. V.N. Viswanadhan Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics J. Chem. Inf. Comput. Sci. 29 1989 163 172
31. X.H. Ma Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries Comb. Chem. High Throughput Screen. 12 2009 344 357
32. A. Nicholls Molecular shape and medicinal chemistry: a perspective J. Med. Chem. 53 2010 3862 3886
33. Y.C. Martin Pharmacophore modelling: 2 - applications J.B. Taylor, D.J. Triggle, Comprehensive Medicinal Chemistry II 2007 Elsevier Ltd 515 536
34. K-H. Kim Pharmacophore-based virtual screening: a review of recent applications Expert Opin. Drug Discov. 5 2010 205 222
35. H-J. Boehm The computer program LUDI: a new method for the de novo design of enzyme inhibitors J. Comput. Aid. Mol. Des. 6 1992 61 78
36. G. Wolber, and T. Langer LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters J. Chem. Inf. Model. 45 2005 160 169
37. S. Olla Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors Bioorg. Med. Chem. Lett. 19 2009 1512 1516
38. H. Yang Structure-based virtual screening for identification of novel 11β-HSD1 inhibitors Eur. J. Med. Chem. 44 2009 1167 1171
39. H. Sun Pharmacophore-based virtual screening Curr. Med. Chem. 15 2008 1018 1024
40. P. Markt Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow J. Med. Chem. 52 2009 369 378
41. Bettati Oxa-azaspiro derivatives: a novel class of triple re-uptake inhibitors ChemMedChem 5 2010 361 366
42. Q. Zhang, and I. Muegge Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting and consensus scoring J. Med. Chem. 49 2006 1536 1548